| Company Name: | Rehabcare Group, Inc. | | Ticker Symbol: | RHB | | | WWW Address: | www.rehabcare.com | | CEO: | Dr. John H. Short, Ph.D. | | No. of Employees: | 6,500 | | Common Issue Type: | CS | | Business Description: | The Company is a provider of rehabilitation program management services in hospitals, skilled nursing facilities, outpatient facilities, and other long-term care facilities in the United States.
|
| | | Industry Information: | HEALTH SERVICES - Hospitals [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 28.01 |  0.06 | 28.0 | 28.02 | 28.19 | 28.07 | 27.24 | 206671 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 518.2 | 18.5 | 0.52 | 1.05 | 0.00 | 18.1 | 0.0 | 28.07 - 12.44 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 27.95 | $ | | PE Ratio - LTM | 18.1 | |
| Market Capitalisation | 497.0 | mil |
| Latest Shares Outstanding | 18.5 | mil |
| Earnings pS (EPS) | 1.05 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 114,323 | $ |
| Effective Tax Rate | 40.7 | % |
| Float | 17.9 | mil |
| Float as % of Shares Outstanding | 96.8 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 19.4 | % |
| EBITDA Margin | 7.7 | % |
| Pre-Tax Profit Margin | 5.4 | % |
| Assets Turnover | 1.9 | % |
| Return on Assets (ROA) | 5.9 | % |
| Return on Equity (ROE) | 9.0 | % |
| Return on Capital Invested (ROCI) | 8.2 | % |
| Current Ratio | 2.0 | |
| Leverage Ratio (Assets/Equity) | 1.5 | |
| Interest Cover | 20.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.09 | |
| LT Debt/Total Capital | 8.0 | % |
| Working Capital pS | 5.20 | $ |
| Cash pS | 1.87 | $ |
| Book-Value pS | 15.95 | $ |
| Tangible Book-Value pS | 5.17 | $ |
| Cash Flow pS | 2.25 | $ |
| Free Cash Flow pS | 2.49 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.75 | |
| Price/Tangible Book Ratio | 5.41 | |
| Price/Cash Flow | 12.4 | |
| Price/Free Cash Flow | 11.2 | |
| P/E as % of Industry Group | 63.0 | % |
| P/E as % of Sector Segment | 135.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 3.4 | 102 | 9,402 | 4,866 |
| 4 Weeks | 28.07 | 18.20 | 18.75 | 49.1 | 140 | 7,164 | 114,625 |
| 13 Weeks | 28.07 | 18.20 | 21.09 | 32.5 | 123 | 2,817 | 169,005 |
| 26 Weeks | 28.07 | 18.20 | 21.82 | 28.1 | 106 | 2,238 | 277,507 |
| 52 Weeks | 28.07 | 12.44 | 14.55 | 92.1 | 156 | 1,971 | 488,871 |
| YTD | 28.07 | 12.44 | - | 84.4 | 151 | 2,006 | 453,331 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 27.15 | 26.33 | 22.40 | 22.21 | 20.58 | 0.52 | 0.74 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 15.99 | 91.6 | 9.57 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 13.16 | NA | -39.85 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 12.0 | 13.9 | 4.4 |
| Earnings % | 59.1 | 42.3 | 47.8 |
| EPS % | 67.6 | 60.9 | 43.8 |
| EPS $ | 0.50 | 0.14 | 0.32 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 22.19 |
| Current Ratio | 2.1 |
| Quick Ratio (Acid Test) | 1.8 |
| Liquidity Ratio (Cash) | 0.30 |
| Receivables Turnover | 5.4 |
| Average Collection Period | 67 |
| Working Capital/Equity | 36.3 |
| Working Capital pS | 5.51 |
| Cash-Flow pS | 1.90 |
| Free Cash-Flow pS | 1.64 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.03 |
| Financial Leverage Ratio (Assets/Equity) | 1.6 |
| Debt Ratio | 38.9 |
| Total Debt/Equity (Gearing Ratio) | 0.21 |
| LT Debt/Equity | 0.21 |
| LT Debt/Capital Invested | 24.4 |
| LT Debt/Total Liabilities | 33.4 |
| Interest Cover | 9.1 |
| Interest/Capital Invested | 1.12 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 6.99 |
| Tobin's Q Ratio | 1.13 |
| Current P/E Ratio - LTM | 18.10 |
| Enterprise Value (EV)/EBITDA | 13.46 |
| Enterprise Value (EV)/Free Cash Flow | 41.90 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 5.41 |
| Price/Book Ratio - LTM | 1.75 |
| Price/Cash Flow Ratio | 12.4 |
| Price/Free Cash Flow Ratio - LTM | 11.2 |
| Price/Sales Ratio | 0.64 |
| P/E Ratio (1 month ago) - LTM | 13.1 |
| P/E Ratio (26 weeks ago) - LTM | 17.2 |
| P/E Ratio (52 weeks ago) - LTM | 14.1 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 63.0 |
| P/E as % of Sector Segment | 135.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 17.5 |
| PER SHARE FIGURES |
| LT Debt pS | 3.23 |
| Current Liabilities pS | 5.17 |
| Tangible Book Value pS - LTM | 5.17 |
| Book Value pS - LTM | 15.95 |
| Capital Invested pS | 17.60 |
| Cash pS - LTM | 1.87 |
| Cash Flow pS - LTM | 2.25 |
| Free Cash Flow pS - LTM | 2.49 |
| Earnings pS (EPS) | 1.05 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 3.89 |
| Free Cash Flow Margin 5YEAR AVG | -2.11 |
| Net Profit Margin | 2.5 |
| Net Profit Margin - 5YEAR AVRG. | 1.5 |
| Equity Productivity | 2.78 |
| Return on Equity (ROE) | 7.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 4.0 |
| Capital Invested Productivity | 2.29 |
| Return on Capital Invested (ROCI) | 5.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 3.3 |
| Assets Productivity | 1.80 |
| Return on Assets (ROA) | 4.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | 2.5 |
| Gross Profit Margin | 19.4 |
| Gross Profit Margin - 5YEAR AVRG. | 21.0 |
| EBITDA Margin - LTM | 7.7 |
| EBIT Margin - LTM | 5.7 |
| Pre-Tax Profit Margin | 4.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 3.4 |
| Effective Tax Rate | 40.7 |
| Effective Tax Rate - 5YEAR AVRG. | -40.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 67 |
| Revenue per Employee | 114,323 |
| Net Income per Employee | 2,878 |
| Average Collection Period | 67 |
| Receivables Turnover | 5.4 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.12 |
| Assets/Revenue | 0.56 |
| Net Working Capital Turnover | 7.64 |
| Fixed Assets Turnover | 2.97 |
| Total Assets Turnover | 1.8 |
| Revenue per $ Cash | 27.15 |
| Revenue per $ Plant | 19.63 |
| Revenue per $ Common Equity | 2.78 |
| Revenue per $ Capital Invested | 2.29 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 12.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 12.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |